Please use this identifier to cite or link to this item: http://repository.i3l.ac.id/jspui/handle/123456789/159
Full metadata record
DC FieldValueLanguage
dc.contributor.authorCanamara, Shannon-
dc.date.accessioned2021-10-26T06:28:09Z-
dc.date.available2021-10-26T06:28:09Z-
dc.date.issued2019-12-19-
dc.identifier.urihttp://repository.i3l.ac.id/jspui/handle/123456789/159-
dc.description.abstractColorectal cancer (CRC) is one of the most common types of cancer happening to both men and women in all race and ages, accounting 9% of all cancer incidence worldwide. In 2018 alone, there are 1.8 million new cases and almost 900,000 deaths. Causes of CRC varies into environmental and non-modifiable factors. As for the non-modifiable factors, the most established risk is inherited genetic risk where the cause of it is due to inherited mutation of specific gene called GREM1, a gene from a protein Gremlin-1 (Grem1). Grem1 is an antagonist to a secreted signaling molecule called bone morphogenetic protein (BMP) that work in tandem with its antagonist to regulate development of kidney, lung, limbs, digestive organs, and some other systems. Despite knowing Grem1’s role in human organ development, its role in carcinogenesis is yet to be studied in detail. In this project, three main experiments, with HeLa cells used as initial cancer cell model and tissues of mouse intestine for visualization, were set up to understand better Grem1’s role in cancer cells. Result showed that Grem1 was able to bind with HeLa cells as transfection was confirmed through western blotting. pSmad 1/5 immunohistochemistry staining showed that Grem1 was in abundance at the base of the mouse colonic crypt but sparse to none found at the villi towards the tip. MTT assay results showed that Grem1 was capable to increase cell viability of HeLa cells, even after damaged by apoptosis inducing agent, H2O2.en_US
dc.publisherIndonesia International Institute for Life Sciencesen_US
dc.relation.ispartofseriesBM 19-019;T201912019-
dc.subjectColorectal canceren_US
dc.subjectnon-modifiable factorsen_US
dc.subjectGREM1en_US
dc.subjectGremlin-1en_US
dc.subjectantagonisten_US
dc.subjectbone orphogenetic protein (BMP)en_US
dc.subjectregulate developmenten_US
dc.subjectcarcinogenesisen_US
dc.subjectHeLa cellsen_US
dc.subjecttransfectionen_US
dc.subjectpSmad 1/5en_US
dc.subjectimmunohistochemistryen_US
dc.subjectcolonic crypten_US
dc.subjectMTT assayen_US
dc.subjectcell proliferationen_US
dc.subjectcell viabilityen_US
dc.subjectH2O2en_US
dc.titleIdentification of Novel Mechanisms of Gremlin1 in Canceren_US
dc.typeThesisen_US
Appears in Collections:Biomedicine

Files in This Item:
File Description SizeFormat 
Manuscript Shannon.pdf
  Restricted Access
Full text6.1 MBAdobe PDFView/Open Request a copy
Cover.pdfCover308.91 kBAdobe PDFView/Open
Abstract.pdfAbstract382.38 kBAdobe PDFView/Open
Chapter 1.pdfChapter 1804.23 kBAdobe PDFView/Open
References.pdfReferences411.47 kBAdobe PDFView/Open


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.